Peace of mind is in your hands

Whether a patient is in remission or is currently undergoing treatment.

The sooner cancer recurrence or metastasis is found, ​the sooner the patient can receive appropriate therapy and treatment.

That’s why we’ve created OncoTracking™, a testing program that screens for unique tumor biomarkers in a patient’s blood and may detect signs of cancer recurrence earlier than traditional screening methods.

OncoTracking™ monitors for early signs
of cancer recurrence